Heart rate variability in patients with cardiac hypertrophy--relation to left ventricular mass and etiology

Peter Alter1, Wolfram Grimm, Anna Vollrath

  • 1Department of Internal Medicine-Cardiology, Philipps University of Marburg, D-35033 Marburg, Germany. palter@med.uni-marburg.de

American Heart Journal
|March 30, 2006
PubMed

Insights

Cardiac hypertrophy, regardless of cause, is linked to reduced heart rate variability (HRV). Both patient age and the severity of left ventricular hypertrophy independently predict this decrease in HRV.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Medical Diagnostics

Background:

  • Decreased heart rate variability (HRV) indicates autonomic nervous system disturbances and is linked to increased cardiovascular mortality.
  • Previous research primarily focused on HRV in systolic dysfunction; data on diastolic dysfunction with cardiac hypertrophy is limited.
  • Cardiac hypertrophy, a thickening of the heart muscle, can arise from various conditions.

Purpose of the Study:

  • To investigate heart rate variability (HRV) in patients with cardiac hypertrophy of diverse etiologies.
  • To compare HRV in patients with specific causes of hypertrophy (aortic valve stenosis, hypertrophic cardiomyopathy, hypertensive heart disease) against healthy controls.

Main Methods:

  • Time domain analysis of HRV was conducted using 24-hour Holter electrocardiogram recordings.
  • Eighty-six patients with cardiac hypertrophy and sinus rhythm were analyzed, categorized by etiology.
  • Comparisons were made against 91 healthy control subjects.

Main Results:

  • Patients with aortic valve stenosis, hypertrophic cardiomyopathy, and hypertensive heart disease exhibited significantly reduced HRV (SDNN) compared to controls.
  • The degree of cardiac hypertrophy, assessed by echocardiography, and patient age were identified as independent predictors of decreased HRV.
  • These associations were consistent across different causes of cardiac hypertrophy.

Conclusions:

  • Cardiac hypertrophy from various causes is associated with diminished HRV, detectable via 24-hour Holter monitoring.
  • Increased patient age and the extent of left ventricular hypertrophy are independently linked to reduced HRV.
  • Further research is needed to determine the clinical significance of these HRV alterations in cardiac hypertrophy.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart rate...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...